Actively Recruiting

Age: 5Years - 100Years
All Genders
NCT07228026

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Led by Biometry Inc · Updated on 2026-03-24

160

Participants Needed

13

Research Sites

54 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically meaningful decline in Point Of Care (POC) FeNO as measured by the fenoTRACK device, after an approximately 2-week course of corticosteroid therapy in adults and children with non-steroid treated uncontrolled asthma. 2. Controlled Adult and Pediatric Asthma Subjects: * To evaluate within-session clinical precision during Visit 1 and Visit 2 for the fenoTRACK device for simulated at home FeNO, and at POC * To evaluate within-session clinical precision for home fenoTRACK use

CONDITIONS

Official Title

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

Who Can Participate

Age: 5Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female age 5 years and above
  • Signed informed consent and assent as applicable
  • Diagnosis of asthma
  • Willing and able to perform all study procedures
  • For uncontrolled asthma group: asthma symptoms on at least 2 days per week during the 7 days prior to Visit 1 with at least 3 symptoms from cough, wheezing, shortness of breath, chest tightness, nocturnal awakening, or activity limitation
  • For uncontrolled asthma group: FeNO value of at least 30 ppb if adult or at least 25 ppb if under 18 years on a cleared FeNO device
  • For controlled asthma group: established asthma diagnosis for at least 180 days prior to Visit 1
Not Eligible

You will not qualify if you...

  • Need for immediate emergency department referral
  • Use of oral corticosteroids within 4 weeks prior to Visit 1
  • Use of inhaled corticosteroids within 2 weeks prior to Visit 1
  • Use of biologic therapies within 12 weeks prior to Visit 1
  • Contraindication to corticosteroids
  • Significant non-compliance in a previous clinical trial
  • Participation in another clinical study involving drug, biologic, or device within 30 days or 5 half-lives prior to Visit 1
  • Other significant respiratory conditions such as COPD or cystic fibrosis
  • Employment or relation to Biometry Inc., contract research organizations, investigational sites, or study vendors
  • Any condition making participation undesirable according to the investigator
  • History of smoking 10 or more pack-years or smoking in the 180 days prior to Visit 1
  • Pregnancy or nursing

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 13 locations

1

Bensch Clinical Research LLC

Stockton, California, United States, 95207

Actively Recruiting

2

AllerVie Clinical Research

Panama City, Florida, United States, 32405

Active, Not Recruiting

3

AllerVie Clinical Research

Columbus, Georgia, United States, 31904

Actively Recruiting

4

Paul A Shapero MD

Bangor, Maine, United States, 04401

Actively Recruiting

5

AllerVie Clinical Research

Ellicott City, Maryland, United States, 21043

Actively Recruiting

6

AllerVie Clinical Research

Glenn Dale, Maryland, United States, 20769

Actively Recruiting

7

Nebraska Medical Research Institute, Inc.

Bellevue, Nebraska, United States, 68123-4303

Actively Recruiting

8

Allergy Partners Clinical Research

Asheville, North Carolina, United States, 28803

Actively Recruiting

9

Toledo Institute of Clinical Research Inc

Toledo, Ohio, United States, 43617

Actively Recruiting

10

Orion Clinical Research

Austin, Texas, United States, 78759

Actively Recruiting

11

Pharmaceutical Research & Consulting, Inc.

Dallas, Texas, United States, 75231

Actively Recruiting

12

Western Sky Medical Research

El Paso, Texas, United States, 79912

Actively Recruiting

13

Allergy, Asthma & Sinus Center, S.C.

Greenfield, Wisconsin, United States, 53228

Actively Recruiting

Loading map...

Research Team

V

Vani Bhagwat, M.Sc.

CONTACT

M

Ming Lee, B.Sc.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here